This paper is in the following e-collection/theme issue:

Discretionary Corrigenda (50)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50411, first published .
Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

Authors of this article:

João Estarreja1 Author Orcid Image ;   Priscila Mendes1 Author Orcid Image ;   Carina Silva1, 2 Author Orcid Image ;   Pedro Camacho1 Author Orcid Image ;   Vanessa Mateus1, 3 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics

João Estarreja   1 * , PharmD ;   Priscila Mendes   1 * , MSc, PharmD, PhD ;   Carina Silva   1, 2 * , BSc, MSc, PhD ;   Pedro Camacho   1 * , BSc, MSc, PhD ;   Vanessa Mateus   1, 3 * , MSc, PharmD, PhD

1 Health & Technology Research Center, Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Lisbon, Portugal

2 Centro de Estatística e Aplicações, Universidade de Lisboa, Lisbon, Portugal

3 iMed.ULisboa, Faculdade de Farmacia, Universidade de Lisboa, Lisbon, Portugal

*all authors contributed equally

Corresponding Author:

  • Vanessa Mateus, MSc, PharmD, PhD
  • Health & Technology Research Center
  • Escola Superior de Tecnologia da Saúde
  • Instituto Politécnico de Lisboa
  • Avenida D João II
  • Lote 4.69.01
  • Lisbon, 1990-096
  • Portugal
  • Phone: 1 218980409
  • Email: vanessa.mateus@estesl.ipl.pt